Top Story

FACTOR-64: CCTA screening for CAD failed to reduce 4-year events in diabetes patients

November 17, 2014

Read the Perspective from David C. Goff Jr., MD, PhD

CHICAGO — Screening for CAD by coronary computed tomography angiography did not reduce the composite rate of all-cause mortality, nonfatal MI or hospitalization for unstable angina at 4 years in asymptomatic patients with diabetes, despite use of coronary interventions and favorable trends in lipids and BP.

Prior attempts at screening for asymptomatic CAD had been limited to noninvasive tests with variable sensitivity and specificity that were capable of identifying only obstructive CAD causing myocardial ischemia, according to Joseph B. Muhlestein, MD, from Intermountain Medical Center Heart Institute in Murray, Utah, and University of Utah School of Medicine.

Mohammed Ali In the Journals

'Cascade-of-care' displays gaps in US diabetes diagnosis, treatment

November 17, 2014
Using a cascade model to visualize the gaps in awareness of diabetes diagnosis, engagement in care and treatment in the United States, researchers found three of 10…
Meeting News Coverage

DCB shows promise in femoropopliteal arterial disease, diabetes

November 6, 2014
A drug-coated balloon was safe and effective at 12 months in patients with femoropopliteal arterial disease and diabetes, according to findings presented at VIVA…
Healio CMHC2014 Ferdinand2 th Meeting News CoverageVideo

Keith C. Ferdinand, MD, highlights recent data on link between CVDs, diabetes drugs

October 30, 2014
BOSTON — At the Cardiometabolic Health Congress, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at Tulane University School of Medicine in New…
CME
Practical Lipidology

Practical Lipidology: 2013

This activity is supported by an educational grant from Genentech.

The rise in the prevalence of obesity in the last few decades and its growing impact on health has driven the…
More »
Meeting News Coverage Video
thumbnail for video 3857626096001

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
Lipid Forum II Highlights

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »
Meeting News CoveragePerspectivePublication Exclusive

Bariatric surgery provided long-term diabetes control out to 3 years

Cardiology Today, May 2014
WASHINGTON — Three-year data from the STAMPEDE trial demonstrate that significantly more obese patients with diabetes who underwent bariatric…
Meeting News Coverage

EXAMINE: Alogliptin showed no effect on CV mortality, HF hospitalization

March 30, 2014
WASHINGTON — Alogliptin, a dipeptidyl-peptidase IV inhibitor, was not associated with increased risk for CV mortality or hospitalization for…
Meeting News Coverage

EXAMINE: Alogliptin showed no effect on CV mortality, HF hospitalization

Cardiology Today, May 2014
WASHINGTON — Alogliptin, a dipeptidyl-peptidase IV inhibitor, was not associated with increased risk for CV mortality or hospitalization for…
In the Journals

Blood glucose measures offered little benefit for CVD risk prediction

March 25, 2014
Assessment of HbA1c values in the context of CVD risk assessment may provide little incremental benefit for the prediction of CVD risk in people…
In the Journals

Hyperglycemia at hospitalization increased risk for future diabetes in MI patients

March 14, 2014
Approximately one in six patients hospitalized for acute MI have hyperglycemia without known diabetes, and these patients are at a 2.5-fold increased…
In the Journals

Cardiac death, MI remain increased in patients with diabetes treated with DES

March 13, 2014
Among patients treated with drug-eluting stents during the DES era, researchers observed a higher rate of death or MI in those with diabetes compared…
In the Journals

Gestational diabetes may be marker for early atherosclerosis

March 12, 2014
History of gestational diabetes appears to be a marker for early atherosclerosis regardless of pre-pregnancy obesity in women with no subsequent…
In the Journals

Gestational diabetes may be marker for early atherosclerosis

Cardiology Today, April 2014
History of gestational diabetes appears to be a marker for early atherosclerosis regardless of pre-pregnancy obesity in women with no subsequent…
In the Journals

Novel therapy lowered LDL in patients with diabetes, hypercholesterolemia

March 7, 2014
ETC-1002, a novel agent in development by Esperion Therapeutics, lowered LDL levels by nearly 43% in patients with type 2 diabetes and…
In the Journals

Novel therapy lowered LDL in patients with diabetes, hypercholesterolemia

Cardiology Today, April 2014
ETC-1002, a novel agent in development by Esperion Therapeutics, lowered LDL levels by nearly 43% in patients with type 2 diabetes and…
More Headlines »
morganatic-roan
morganatic-roan